SymBiosis Capital Partners, LLC

13F Portfolio Filings

Most recent 13F
Q1 2026
13D/G filings
13G on 2 securities
Location
Bentonville, AR
CIK
0002006045
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q1 2026 6 52,769 Evommune, Inc., IVA, WVE, RANI 13F-HR 5/12/2026 000200604526000007
Q4 2025 11 109,495 Evommune, Inc., VSTM, AMPG, PGEN 13F-HR 2/12/2026 000200604526000002

13D and 13G Filings

All 13D and 13G filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G.

2 securities where the latest filing since 12/18/2024 is a 13G, the newest filed 5/15/2026. View all